CHAP’s Board of Directors bring expertise that keeps us forward-thinking.

Maureen A. Spivack

Maureen Spivack's 30 year investment banking career has focused on advising corporate executives and boards on the execution of strategic and financial transactions for publicly traded, privately held and not-for-profit healthcare companies, globally. The combination of her in-depth industry knowledge with expertise in finance, strategy, negotiation, and deal structuring has served to create significant value for stakeholders.

 

Ms. Spivack recently joined  New State Capitol Partners, after working at KPMG Corporate Finance. Prior to that Ms. Spivack was a Managing Director in the Healthcare Investment Banking Group of Morgan Keegan.  Previously, she was a Managing Director in the Global Healthcare Investment Banking Group of UBS.  Prior to UBS, Ms. Spivack spent eight years as Managing Director and Head of the Strategic Advisory Group within the Merrill Lynch Health Care Group.  Prior to Merrill Lynch, Ms. Spivack was a Partner at Ernst & Young, where she ran the National Health Care Corporate Finance practice for 10 years.